Total Holdings
66
Portfolio diversification across 66 positions
HELX
(BATS)Franklin Genomic Advancements ETF
$34.91-- (--)
Loading... - Market loading
HELX ETF Holdings: Franklin Genomic Advancements ETF
Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Assets Under Management
$23.77M
Total fund assets
Expense Ratio
0.50%
Annual management fee
Fund Issuer
Franklin Templeton
BATS
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 50 Holdings by Portfolio Weight
View ticker symbols, company names, asset types, and allocation percentages for each position
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | Natera, Inc | Stock | 7.04% |
| 2 |  | Guardant Health, Inc | Stock | 6.96% |
| 3 |  | Krystal Biotech, Inc. | Stock | 5.29% |
| 4 |  | Insmed Incorporated | Stock | 4.96% |
| 5 |  | Medpace Holdings, Inc. | Stock | 4.48% |
| 6 |  | Alnylam Pharmaceuticals, Inc | Stock | 4.07% |
| 7 |  | BridgeBio Pharma, Inc | Stock | 3.64% |
| 8 |  | United Therapeutics Corporation | Stock | 3.60% |
| 9 |  | Adaptive Biotechnologies Corporation | Stock | 3.55% |
| 10 | K KRX:207940 | Samsung Biologics Co.,Ltd. | Stock | 3.37% |
| 11 |  | Ligand Pharmaceuticals Incorporated | Stock | 3.25% |
| 12 | K KO:207940 | Samsung Biologics Co Ltd | Stock | 3.03% |
| 13 | L LON:AZN | AstraZeneca PLC | Stock | 3.00% |
| 14 |  | Vertex Pharmaceuticals Incorporated | Stock | 2.94% |
| 15 |  | Tempus AI, Inc. Class A Common Stock | Stock | 2.87% |
| 16 |  | GeneDx Holdings Corp. | Stock | 2.73% |
| 17 |  | Eli Lilly and Company | Stock | 2.71% |
| 18 |  | AstraZeneca PLC | Stock | 2.64% |
| 19 |  | Regeneron Pharmaceuticals, Inc. | Stock | 2.47% |
| 20 |  | Exact Sciences Corporation | Stock | 2.42% |
| 21 |  | Corteva, Inc. | Stock | 2.24% |
| 22 |  | Ionis Pharmaceuticals, Inc. | Stock | 2.22% |
| 23 |  | BioNTech SE | Stock | 2.05% |
| 24 |  | GRAIL, LLC | Stock | 1.77% |
| 25 | E EBR:ARGX | Argen-X | Stock | 1.73% |
| 26 |  | Neurocrine Biosciences, Inc. | Stock | 1.66% |
| 27 |  | PTC Therapeutics, Inc. | Stock | 1.50% |
| 28 |  | Travere Therapeutics Inc | Stock | 1.46% |
| 29 |  | Veracyte, Inc | Stock | 1.09% |
| 30 |  | Charles River Laboratories International, Inc | Stock | 1.08% |
| 31 | E ETR:SRT3 | Sartorius Aktiengesellschaft | Stock | 1.03% |
| 32 |  | Repligen Corporation | Stock | 1.02% |
| 33 |  | Danaher Corporation | Stock | 0.97% |
| 34 |  | IQVIA Holdings Inc | Stock | 0.92% |
| 35 |  | Thermo Fisher Scientific Inc | Stock | 0.92% |
| 36 |  | Ultragenyx Pharmaceutical Inc | Stock | 0.87% |
| 37 |  | Twist Bioscience Corporation | Stock | 0.87% |
| 38 |  | Beam Therapeutics Inc | Stock | 0.83% |
| 39 |  | Stoke Therapeutics, Inc | Stock | 0.78% |
| 40 |  | CRISPR Therapeutics AG | Stock | 0.75% |
| 41 |  | Cadence Design Systems, Inc | Stock | 0.75% |
| 42 |  | Agilent Technologies, Inc | Stock | 0.69% |
| 43 |  | QIAGEN N.V | Stock | 0.64% |
| 44 |  | Doximity, Inc. | Stock | 0.61% |
| 45 |  | CareDx, Inc | Stock | 0.59% |
| 46 |  | Jazz Pharmaceuticals plc | Stock | 0.57% |
| 47 |  | Arcutis Biotherapeutics, Inc | Stock | 0.52% |
| 48 |  | Catalyst Pharmaceuticals Inc | Stock | 0.52% |
| 49 |  | Hinge Health, Inc. | Stock | 0.44% |
| 50 |  | Rhythm Pharmaceuticals, Inc | Stock | 0.42% |